ortho-Bromophenylpiperazine (oBPP), also known as 2-bromophenylpiperazine (2-BPP), is a monoamine releasing agent of the phenylpiperazine family. It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA), with EC50Tooltip half-maximal effective concentration values of 132nM for serotonin, 33nM for norepinephrine, and 250nM for dopamine in rat brain synaptosomes. The drug was first described in the scientific literature by 2012.

See also